Has John Bacharach, MD received payments from drug or device companies?

Yes. Drug and device makers reported $17,889 in general payments to John Bacharach, MD across 160 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Bacharach, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Bacharach, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Bacharach, MD

Cardiovascular Disease · Sioux Falls, SDNPI 1972566172

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (34.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Surmodics, Inc. at 31.1% of the total. Reporting peaked in 2023 at $8,460 and has fallen 89.8% since, to $861 in 2025.

$17,889in general payments, 2019–2025

Across 160 payments — averaging $111.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Surmodics, Inc.$6K
Contego Medical, Inc$3K
Abbott$2K
W. L. Gore & Associates, Inc.$2K
Medtronic$2K
Boston Scientific$867
plus $3K from 18 others

$483,142in research payments, 2019–2025

Across 93 payments — averaging $5195.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sanofi Pasteur Inc.$208K
Contego Medical, Inc$120K
Surmodics, Inc.$62K
Microvention, Inc.$42K
Endologix LLC$16K
Inspiremd Ltd$10K
plus $24K from 4 others

What the payments were for

Consulting fees$5,98333%
Speaking & faculty fees$7504%
Travel & lodging$4,97428%
Food & beverage$6,18235%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Surmodics, Inc.	3	$5,556
Contego Medical, Inc	3	$2,913
Abbott	25	$2,021
W. L. Gore & Associates, Inc.	22	$1,738
Medtronic(2 entities)	34	$1,547
Boston Scientific	21	$867
Edwards Lifesciences	17	$729
Cordis US CORP.	2	$692
Inspiremd Ltd	1	$456
Inari Medical, Inc.	2	$266
Shockwave Medical, Inc	9	$243
Silk Road Medical, Inc.	2	$155
Penumbra, Inc.	2	$123
Abiomed	4	$107
Davol Inc.	1	$100
Cardiva Medical, Inc.	3	$80
Shape Memory Medical Inc.	1	$55
Reflow Medical Inc	1	$52
Asahi Intecc USA, Inc.	1	$51
Biosense Webster, Inc.	2	$39
Angiodynamics, Inc.	1	$32
Stryker	1	$31
Terumo Medical Corporation	1	$17
Cook Medical LLC	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,889 in reported general payments places this provider in the 85th percentile of 33 cardiovascular disease providers in South Dakota.

See all cardiovascular disease providers in South Dakota →

Medicare billing

Part B allowed, 2024

$373,276

Medicare patients

1,451

Services billed

3,650

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	92	$62,815
BrilintaTicagrelor	20	$15,917
Repatha SureclickEvolocumab	13	$7,178
XareltoRivaroxaban	13	$6,752
ClopidogrelClopidogrel Bisulfate	297	$1,792
Atorvastatin Calcium	98	$547
Metoprolol Tartrate	48	$218
Metoprolol Succinate	15	$192
Hydrochlorothiazide	25	$80
Losartan Potassium	12	$53
Furosemide	23	$40
Carvedilol	13	$28
Lisinopril	19	$25

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Sioux Falls

Naveen RajpurohitSioux Falls$68K
Kevin VaskaSioux Falls$24K
Udit BhatnagarSioux Falls$19K
Mahmoud SharafSioux Falls$11K
Maria StysSioux Falls$3K
Christopher PaaSioux Falls$3K
Richard ClarkSioux Falls$2K
Amjad Panickaveettil Mohamed BasheerSioux Falls$1K
Fawzi AmeerSioux Falls$1K
Sherrie BrooksSioux Falls$1K

See the full list for South Dakota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →